BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12041782)

  • 1. In-vitro and in-vivo activity of roxithromycin against Chlamydia trachomatis.
    Furneri PM; Sardo S; Cianci A; Palumbo G; Tempera G
    J Chemother; 1991 Jan; 3 Suppl 1():36-8. PubMed ID: 12041782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro activity of roxithromycin against Chlamydia trachomatis.
    Moroni A; Sambri V; Rumpianesi F; Donati M; Cevenini R
    J Chemother; 1991 Jan; 3 Suppl 1():28-9. PubMed ID: 12041779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single dose (direct observed) azithromycin therapy for Neisseria gonorrhoeae and Chlamydia trachomatis in STD clinic attenders with genital discharge in Trinidad and Tobago.
    Swanston WH; Prabhakar P; Barrow L; Mahabir BS; Furlonge C
    West Indian Med J; 2001 Sep; 50(3):198-202. PubMed ID: 11769023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rokitamycin in the treatment of female genital Chlamydia and Mycoplasma infections. Comparative study vs josamycin ].
    Colombo U; Pifarotti G; Amidani M; Viezzoli T; Pifarotti P
    Minerva Ginecol; 1998 Nov; 50(11):491-7. PubMed ID: 9882991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Roxithromycin versus doxycycline in the treatment of Chlamydia trachomatis cervicitis in asymptomatic women].
    Rosales M; Domínguez V; Bonacho I; Vidal X
    Rev Clin Esp; 1993 Apr; 192(6):253-5. PubMed ID: 8497717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative randomized pilot study of azithromycin and doxycycline efficacy in the treatment of prostate infection caused by Chlamydia trachomatis.
    Skerk V; Krhen I; Lisić M; Begovac J; Roglić S; Skerk V; Sternak SL; Banaszak A; Strugar-Suica J; Vuković J
    Int J Antimicrob Agents; 2004 Aug; 24(2):188-91. PubMed ID: 15288321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report.
    Wang SA; Papp JR; Stamm WE; Peeling RW; Martin DH; Holmes KK
    J Infect Dis; 2005 Mar; 191(6):917-23. PubMed ID: 15717267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which treatment for genital tract Chlamydia trachomatis infection?
    Tobin JM; Harindra V; Mani R
    Int J STD AIDS; 2004 Nov; 15(11):737-9. PubMed ID: 15537459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily oral grepafloxacin vs. twice daily oral doxycycline in the treatment of Chlamydia trachomatis endocervical infection.
    McCormack WM; Martin DH; Hook EW; Jones RB
    Infect Dis Obstet Gynecol; 1998; 6(3):109-15. PubMed ID: 9785106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Our experience in treating pelvic inflammatory disease caused by Chlamydia trachomatis with the preparation roxithromycin].
    Damianov L; Dukovski A; Novachkov V; Kolarov G; Katsarova M
    Akush Ginekol (Sofiia); 1995; 34(1):16-8. PubMed ID: 7485792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of ofloxacin in the treatment of mucopurulent cervicitis: response of chlamydia-positive and chlamydia-negative forms.
    Chandeying V; Sutthijumroon S; Tungphaisal S
    J Med Assoc Thai; 1989 Jun; 72(6):331-7. PubMed ID: 2778422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection.
    Falk L; Fredlund H; Jensen JS
    Sex Transm Infect; 2005 Feb; 81(1):73-8. PubMed ID: 15681728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of in vitro activity of ofloxacin against 73 strains of Chlamydia trachomatis isolated from gynecologic infections].
    Catalan F; Milovanovic A; Prouteau C; Soulignac M
    Pathol Biol (Paris); 1998 Feb; 46(2):144-6. PubMed ID: 9769927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azithromycin in the treatment of chlamydial cervicitis and eradication of Ureaplasma urealyticum in female lower genital tract.
    Charoenwatanachokchai A; Chitwarakorn A; Siriwongrangsun P; Pariyasak W; Yenyasun N; Sukwit S
    J Med Assoc Thai; 1997 Jun; 80(6):343-7. PubMed ID: 9240007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic susceptibility testing for Chlamydia trachomatis using flow cytometry.
    Dessus-Babus S; Belloc F; Bébéar CM; Poutiers F; Lacombe F; Bébéar C; de Barbeyrac B
    Cytometry; 1998 Jan; 31(1):37-44. PubMed ID: 9450523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of ciprofloxacin against Chlamydia trachomatis and Ureaplasma urealyticum.
    Rumpianesi F; Sambri V; Bertini S; Tamba I; Cevenini R
    Chemioterapia; 1984 Jun; 3(3):173-4. PubMed ID: 6529772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiological study of Chlamydia trachomatis infection in a sample of women requesting voluntary termination of pregnancy, treated with rokitamycin].
    Carta E; Marletta A; Artuso A; Chiodi S; Consoli R; Fasce V; Paccagnella F; Palmonella G; Spinelli S; Guerini Rocco C
    Minerva Ginecol; 2000; 52(1-2):33-9. PubMed ID: 10851862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Roxithromycin (Rulid) in treatment of Chlamydia trachomatis genital infections in women].
    Radowicki S; Tyc M; Kulesza E; Dowgiałło-Smolarczyk J
    Ginekol Pol; 1995 Jun; 66(6):354-6. PubMed ID: 8522242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genital chlamydial infection.
    Low N; Cowan F
    Clin Evid; 2002 Jun; (7):1409-15. PubMed ID: 12230756
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bacteriostatic and bactericidal activities of cyclines, macrolides and fluoroquinolones against Chlamydia trachomatis].
    Dailloux M; Villemain P
    Pathol Biol (Paris); 1992 May; 40(5):455-60. PubMed ID: 1495827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.